Neuronal damage is damage to nerve cells, most often caused by decreased blood flow, alcohol or drug abuse, neurological disorders such as Alzheimer’s disease, cerebral palsy, and stroke, and trauma or other insults to the brain. Neuronal damage severely impairs the functioning of the nervous system, resulting in physical, cognitive, and emotional disabilities. The physical symptoms of neuronal damage can vary depending on the cause and extent of damage. Common physical symptoms include paralysis, loss of sensation, difficulty in movement, and difficulty in speaking or understanding language. Cognitive and emotional symptoms may include confusion, memory loss, difficulty in concentrating, and depression. Neuronal damage can also lead to changes in perception, spatial orientation, personality, and other behaviors. The effects of neuronal damage can be long lasting and, in some cases, irreversible. There are, however, several treatments available to help mitigate the effects of neuronal damage. Some treatments focus on physical rehabilitation to restore movement and sensation. Others increase oxygen in the brain to help improve the functioning of damaged neurons. Medications such as antidepressants and mood stabilizers can be effective in treating the emotional and behavioral symptoms of neuronal damage. It is important to seek medical advice and treatment as soon as possible if you are concerned or suspect that you or a loved one may be experiencing neuronal damage. Early detection and treatment can help reduce the extent of harm and allow individuals to lead fuller and healthier lives.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States